R21CA240148 (ANGEL, PEGGY M)Aug 1, 2019 - Jul 31, 2021 NIH Enzymatic Tools for 2D Tissue Localized and Deeper Proteomic Sequencing of Cancer Stromal Proteins Role: Co-Investigator |
|
R01AI138511 (VASU, CHENTHAMARAKSHAN)Nov 6, 2018 - Oct 31, 2023 NIH Role of microbiota-TLR7/8 Interaction in systemic lupus erythematosus Role: Co-Investigator |
|
S10OD025126 (BALL, LAUREN ELIZABETH)Aug 3, 2018 - Aug 2, 2019 NIH Orbitrap Fusion Lumos ETD Mass Spectrometer Role Description: ThermoScientific Orbitrap Fusion Lumos Mass Spectrometer with ETD and UVPD. High End Shared Instrumentation Grant ($991,000) to purchase state-of-the-art LC-MS/MS-based proteomics instrumentation for the MUSC Mass Spectrometry Facility. Role: Principal Investigator |
|
R35GM126955 (LUTTRELL, LOUIS M)May 1, 2018 - Apr 30, 2023 NIH Pharmacodynamics of Biased G Protein-Coupled Receptor Agonism Role: Co-Investigator |
|
R21DE025920 (PALANISAMY, VISWANATHAN)Jan 1, 2017 - Dec 31, 2018 NIH Comprehensive Identification of FXR1 Targets Using pSILAC-BONCAT Proteomics Role: Co-Investigator |
|
S10OD010731 (BALL, LAUREN ELIZABETH)May 1, 2012 - Apr 30, 2013 NIH Orbitrap Mass Spectrometer Role: Principal Investigator |
|
P20GM103542 (TEW, KENNETH D.)Sep 1, 2011 - Jul 31, 2021 NIH South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling Role Description: The goal of the Proteomics Core is to assist COBRE-funded junior investigators investigate signaling mechanisms underlying disease onset/progression; drug effects and resistance; and cellular/systemic metabolic regulation using LC-MS/MS-based quantitative proteomics. Role: Director, Mass Spectrometry Facility and Proteomics Core |
|
R01DE020925 (BALL, LAUREN ELIZABETH)Jul 1, 2010 - Jun 30, 2015 NIH Regulation of IGF-1 and Insulin Signaling by O-GlcNAc Glycosylation Role: Principal Investigator |
|
R01DK073336 (LEMASTERS, JOHN J)Mar 20, 2007 - Aug 31, 2018 NIH Mechanisms of I/R Injury to Hepatocytes Role: Co-Investigator, 2014-2016 |
|
IRG-97-219-08 (REED, CAROLYN E)Jan 1, 2007 - Dec 31, 2008 American Cancer Society Regulation of Growth Factor Signaling by O-GlcNAc Glycosylation Role: Pilot Project PI, 2007-2008 |
|
W81XWH-07-1-0691 (EBLEN, SCOTT T)Jun 1, 2006 - May 31, 2010 DOD/US ARMY Regulation of Senescence by p38 MAP Kinase in ErbB-2-Induced Breast Cancer Role: Co-Investigator |
|
3-2005-337 (BALL, LAUREN E)Jun 1, 2005 - Sep 1, 2006 Juvenile Diabetes Research Foundation Role of the Hexosamine Pathway in Vascular Complications of Diabetes. Role Description: Post-Doctoral Fellowship Role: Principal Investigator |
|
5U24DE016508-02 (SLATE, ELIZABETH H)Sep 27, 2004 - Aug 31, 2008 NIH Oral Health Research Infrastructure Development at MUSC Role Description: Start up funds for faculty recruitment. Role: Recruited Faculty, 2006 |
|
P20RR017696 (KIRKWOOD, KEITH L)Sep 30, 2002 - Jul 31, 2013 NIH South Carolina COBRE for Oral Health Research Role Description: The goal of this study is to detect and functionally evaluate the role of glucose-induced O-GlcNAc modification of insulin receptor substrate (IRS1) in diabetic complications including alveolar bone loss. Role: Sub-Project PI, 2008-2010 |
|
R01DK055524 (LUTTRELL, LOUIS M)Sep 25, 1998 - Apr 30, 2018 NIH Tyrosine Kinases in G Protein Mediated Signaling Role: Co-Investigator, 2014-2018 |
|
9732152 (CROUCH, ROSALIE K)Jun 16, 1998 - May 31, 2000 NSF Div of Biol Infrastructure REU Site in Cellular Signal Transduction Role Description: The goal of this study was to detect age-related post-translational modifications of an integral membrane water channel, Aquaporin 0, by LC-MS/MS during the course of aging and cataract development. Role: Pre-Doctoral Fellow, 1998-2000 |
|
R01DK002001 (BUSE, MARIA G)May 1, 1978 - Feb 28, 2014 NIH Factors that modify insulin action Role Description: The goal of Aim 2 (2009-2014) led by Dr. Ball is to test the hypothesis that O-GlcNAc modification of IRS1 attenuates hepatic insulin signaling. Role: Co-Investigator, 2009-2014 |
|
T32HL007260 (MENICK, DONALD R.)Jul 1, 1977 - Jun 30, 2022 NIH Training To Improve Cardiovascular Therapies Role Description: The goal of this study was to evaluate the role of O-GlcNAc Transferase (OGT), O-GlcNAcase (OGA), and protein O-GlcNAc modification in the development of diabetic complications. Role: Post-Doctoral Fellow, 2003-2004 |